Picard Medical Inc
Research Picard Medical Inc (PMI) on Bullrun: market cap USD 891.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPMI
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 891.49M
- Financial periodQ1 2026
- RevenueUSD 1.15M
- Net income-USD 7.62M
- Free cash flow-USD 3.83M
- Gross margin23.9%
Valuation Snapshot
latest market cap is USD 891.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 4.94M | -USD 27.00M | -USD 15.67M | -4.1% | -0.75 | USD 7.45M | USD 6.98M | USD 3.79M |
| FY2024 | USD 4.39M | -USD 21.06M | n/a | -2.6% | -2.99 | USD 96.00K | USD 20.93M | -USD 44.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 891.49M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 128.98M | n/a | n/a | n/a |
About Picard Medical Inc
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Picard Medical Inc's market cap?
Picard Medical Inc's market capitalization is USD 891.49M.
What does Picard Medical Inc do?
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.